AstraZeneca
AI-driven solution boosts engagement and reduces costs for leading pharmaceutical company.
Credera partnered with AstraZeneca to design and implement an AI-powered virtual assistant that increased healthcare professional engagement by 196% and generated over $3M in cost savings.
At a Glance
AstraZeneca, a leading global pharmaceutical company, recognized that oncologists found it challenging to stay updated with the latest medical advancements, creating barriers to optimal patient care. Credera partnered with them to design and implement an AI-powered virtual assistant that would provide healthcare professionals (HCPs) with real-time, precise oncology information.
In 3 1/2 months, Credera delivered a groundbreaking solution that enhanced HCP access to critical medical insights and established a scalable foundation for future AI initiatives across the organization.
The Challenge
Bridging the gap between medical advancement and HCP accessibility
Healthcare professionals face increasing demands and complexities in staying current with rapidly evolving oncology treatments. AstraZeneca needed a solution that would deliver concise information while enabling deeper exploration of topics in a streamlined experience. The challenge was to create a platform that could handle routine HCP inquiries efficiently while maintaining the standards of medical accuracy and regulatory compliance required in the pharmaceutical industry.
The Solution
Delivering precision-driven AI innovation in record time
Credera began with a comprehensive 5-week proof-of-concept phase to deliver strategic recommendations and a robust prototype. Following stakeholder workshops, we designed and built an enterprise-grade AI virtual assistant featuring precision-driven medical content that offers regulatory-compliant, concise information to instill confidence among HCPs.
The solution incorporated dynamic-interaction prompts for rapid information discovery, advanced contextual understanding for intuitive follow-up queries, and seamless integration with the company's existing medical website infrastructure.
Our specialists also implemented a comprehensive content management system, trained natural language processing models to achieve accuracy across multiple oncology brands, and developed user experience interfaces aligned with pharmaceutical industry standards.
The platform was built with enterprise scalability in mind, establishing technical foundations for future innovations across the enterprise while ensuring full regulatory compliance and automated quality assurance processes.
The Results
Transforming HCP engagement and operational efficiency
AstraZeneca now has a state-of-the-art AI platform that provides immediate oncology information while creating enduring value across the enterprise. As a result of this initiative, the company has realized:
Enhanced HCP engagement: 196% increase in engagement
Improved operational efficiency: Reduced cost per engagement by leveraging the chatbot to handle routine HCP inquiries
Superior user experience: Higher click rates for downloadable materials and extremely positive feedback ratings
Regulatory compliance: Consistent, compliant automated HCP query responses, reducing compliance costs
A strategic foundation: A scalable platform ready for future AI innovations across the enterprise, with a roadmap for global expansion and multi-channel integration
Contact Us
Let's talk!
We're ready to help turn your biggest challenges into your biggest advantages.
Searching for a new career?
View job openings
